Click to open contact form.
Your Global Partners in the Business of Innovation



Medical cannabis has undoubtedly become one of the world’s fastest-growing, ever-changing and most innovative sectors. The immense potential of the drug has led to a new global industry that was worth around USD 13.4 billion in 2018 and is estimated to reach over USD 44 billion by 2024, according to research. But this is a complex new area, with laws and regulations varying across jurisdictions. As cannabis becomes more mainstream, there are unique challenges facing cannabis-related businesses (CRBs) as they enter unchartered territory.

Pearl Cohen’s Cannabis group has developed an unrivalled level of experience at the heart of the medical cannabis industry, with Israel particularly becoming a lead exporter of innovative technological inventions in the medical cannabis field. Our wealth of industry knowledge, deep familiarity with the regulatory landscape and seamless cooperation with all our expert departments enable clients to confidently seize the business opportunities that lie before them.

In particular, we are a prime destination for the IPOs of medical cannabis companies, having engaged with most of the medical cannabis companies in Israel and taking many of our clients public over the last few years. Since many CRBs are entrepreneurial in nature, we also play a critical role in serving as outside general counsel, advising on mergers and acquisitions, investments and financings, capital markets and securities issues, regulatory compliance, intellectual property – patent and trademark protection and enforcement, litigation and other day-to-day operational advice.

Pearl Cohen’s deep commitment to the cannabis space is best reflected by the raft of cutting-edge medical cannabis manufacturers, operators, marketers and investors in our extensive roster, including Panaxia Pharmaceutical Industries, one of the largest players in pharmaceutical cannabis in Israel, InterCure Ltd. a Tel Aviv-listed medical cannabis company with former Israeli Prime Minister Mr. Ehud Barak as chairman, Together Pharma, Medivie Therapeutic, Cannomed Medical Cannabis Industries and many more.